PEPID’s clinical and pharmacological content is designed to support clinicians through every stage of the decision support process, increasing safety and accuracy through better-informed patient care.

PEPID said that it contains the extensive drug database on the market along with disease profiles and medical conditions, medical and dosing calculators, a drug interactions checker, illustrations, laboratory values, and a differential diagnosis generator, all of which are available on the iPad PEPID beta application.

iPad president John Wagner said that the iPad is the latest to join the PEPID family of applications and continues corporate mandate to make PEPID’s content available to healthcare professionals anytime, anyplace regardless of the device they use.

PEPID chief technology officer Edward Reynolds said that they are excited about the release of PEPID’s beta for the Apple iPad and their development team is working to maximise the usability and potential of the iPad in healthcare settings.